Table 1.
Characteristics of clinical and biochemical parameters before and after induction therapy with infliximab
| Parameter |
Week 0 |
Week 8 |
P value | ||||||
| mean | Median | Q1 | Q3 | mean | Median | Q1 | Q3 | ||
| PUCAI score | 49.1 | 50 | 35 | 65 | 16.3 | 10 | 10 | 20 | < 0.05 |
| Body weight (kg) | 46.5 | 44 | 43 | 56.6 | 50.4 | 53.3 | 42.7 | 60.5 | < 0.05 |
| Body height (cm) | 157.3 | 163 | 151 | 168.5 | 158.2 | 163.5 | 152 | 170 | NS |
| Hemoglobin (g/dL) | 9.9 | 9.8 | 8.3 | 11.3 | 11 | 11 | 10 | 12.2 | < 0.05 |
| Hematocrit (%) | 35.8 | 31.5 | 29.2 | 35.8 | 33.9 | 34.9 | 30.1 | 37.2 | NS |
| Platelet count (K/μL) | 441.1 | 427 | 327.5 | 558 | 384 | 375.5 | 290 | 440.5 | NS |
| ESR (mm/h) | 33 | 36 | 18.5 | 45 | 19.8 | 12.5 | 7 | 22.5 | < 0.05 |
| CRP (mg/dL) | 2.6 | 2.8 | 0.4 | 4.1 | 0.3 | 0.2 | 0 | 0.4 | < 0.05 |
Q1: Lower quartile; Q3: Upper quartile; NS: Not significant.